CSL Behring Australia is undergoing extensive and positive change as we expand. In addition to contributing to Australia's export economy, CSL has invested and continues to invest in substantial new manufacturing facilities to support CSL's global strategy and provide the network with crucial supply of finished / intermediates sourced from our Australian facilities.
As part of the BACE II Project, which will deliver a major expansion to the AlbuRx production capacity on the Broadmeadows site, an important position has been identified to support the project delivery, being a Project Manager – BACE II Bulk Lead.
You will be a critical member of the Project Delivery team and will lead the delivery of the bulk process scope for the BACE II Project.
Reporting to the Project Delivery Lead you will:
Apply to join CSL Behring in an important role with our Project Delivery group and join a purpose-driven, values-based company committed to protecting public health!
Applications close Monday 20th March 2023.
#LI-onsite
We encourage you to make your well-being a priority. It’s important and so are you. Learn more about how we care at CSL.
CSL Behring is a global leader in developing and delivering high-quality medicines that treat people with rare and serious diseases. Our treatments offer promise for people in more than 100 countries living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. Learn more about CSL Behring.
As a global organisation with employees in 35+ countries, CSL embraces diversity and inclusion. Learn more about Diversity & Inclusion at CSL.